Here are five observations:
1. In 2016, the market was worth $10.2 billion; by 2025 the market will likely reach $16.7 billion.
2. A boost in the number of spine surgeries using bone grafts and bone morphogenetic proteins as well as electrical stimulation devices will expand the global market.
3. In 2016, the vertebral fracture repair segment led the market. A rise in spinal fusions in the Asia-Pacific region and Latin America, among other factors, will allow the segment capture the second highest market share by 2025.
4. Hospitals will remain the leading end user of spine surgery products through 2025.
5. Stryker, Medtronic, Zimmer Biomet, Globus Medical, K2M, NuVasive, Aesculap Implant Systems, RTI Surgical, Alphatec, Orthofix International and DePuy Synthes are key market players.
More articles on devices:
Providence Medical Technology names new executive; reports 2 new studies: 5 insights
Alphatec reports $25M+ in 2017 revenue — 5 points
SeaSpine to see 2017 revenue of $34M+ — 7 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
